355 related articles for article (PubMed ID: 18640826)
21. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
Tohda Y; Miyamoto T
Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
[TBL] [Abstract][Full Text] [Related]
23. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
24. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
25. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
28. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
Kosoglou T; Cutler DL; Staudinger H; Herron JM
Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
[TBL] [Abstract][Full Text] [Related]
29. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
Pieters WR; Stallaert RA; Prins J; Greefhorst AP; Bosman HG; van Uffelen R; Schreurs AJ; van Helmond JL; Janssen PG
J Asthma; 1998; 35(4):337-45. PubMed ID: 9669827
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
Kempsford RD; Oliver A; Bal J; Tombs L; Quinn D
Respir Med; 2013 Dec; 107(12):1873-80. PubMed ID: 24200619
[TBL] [Abstract][Full Text] [Related]
31. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
34. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
35. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
[TBL] [Abstract][Full Text] [Related]
36. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
Price D; Robertson A; Bullen K; Rand C; Horne R; Staudinger H
BMC Pulm Med; 2010 Jan; 10():1. PubMed ID: 20051135
[TBL] [Abstract][Full Text] [Related]
37. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
Karpel JP; Nelson H
Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
[TBL] [Abstract][Full Text] [Related]
38. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
Busse WW; Bleecker ER; Bateman ED; Lötvall J; Forth R; Davis AM; Jacques L; Haumann B; Woodcock A
Thorax; 2012 Jan; 67(1):35-41. PubMed ID: 21828231
[TBL] [Abstract][Full Text] [Related]
39. Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function.
Rytilä P; Ghaly L; Varghese S; Chung W; Selroos O; Haahtela T;
Eur Respir J; 2008 Oct; 32(4):989-96. PubMed ID: 18508828
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]